Literature DB >> 2930681

High intrinsic radiosensitivity of a newly established and characterised human embryonal rhabdomyosarcoma cell line.

L R Kelland1, L Bingle, S Edwards, G G Steel.   

Abstract

A new human rhabdomyosarcoma cell line (HX170c) has been established from a paratesticular embryonal tumour in a 5-year-old male. The cells grew as an adherent monolayer with a doubling time of 32 h and showed pleomorphic features. Intermediate filament analysis revealed the line to be mesenchymal in origin (reactivity to vimentin and desmin antibodies). The line was tumorigenic in nude mice, possessed elevated levels of creatine phosphokinase (mainly of the MM isoenzyme form) and had a near diploid mean chromosome number of 50. In vitro cell cloning determinations gave colony forming efficiencies of 0.01% in soft agar and 24% in a monolayer anchorage-dependent assay. Radiosensitivity determinations using a monolayer clonogenic assay with feeder layer support showed the cells to be among the more radiosensitive human tumour cell types (surviving fraction at 2 Gy of 0.26) that have been investigated. Furthermore, experiments utilising continuous low dose rate radiation at 3.2 cGy min-1, showed that, under these experimental conditions, the cells possessed only a very low capacity to recover from radiation-induced damage (dose reduction factor at 1% cell survival of 1.07 for 150 versus 3.2 cGy min-1). As other human tumour cells of an embryonal cell origin (e.g. neuroblastoma and germ cell tumours of the testis) have also been shown to be radiosensitive it appears that sensitivity to radiation may be a common property of this group of tumours.

Entities:  

Mesh:

Year:  1989        PMID: 2930681      PMCID: PMC2247019          DOI: 10.1038/bjc.1989.34

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  32 in total

Review 1.  The radiobiology of human tumour cells.

Authors:  G G Steel
Journal:  Br J Radiol Suppl       Date:  1988

2.  A study of a new human tumor cell line (rhabdomyosarcoma).

Authors:  A L Chapman; P Bogner; A M Behbehani
Journal:  Proc Soc Exp Biol Med       Date:  1974-09

3.  Cultivation in vitro of cells derived from a human rhabdomyosarcoma.

Authors:  R M McAllister; J Melnyk; J Z Finkelstein; E C Adams; M B Gardner
Journal:  Cancer       Date:  1969-09       Impact factor: 6.860

4.  Intermediate filaments: cell-type-specific markers in differentiation and pathology.

Authors:  M Osborn; K Weber
Journal:  Cell       Date:  1982-12       Impact factor: 41.582

5.  Inherent cellular radiosensitivity as a basic concept for human tumor radiotherapy.

Authors:  B Fertil; E P Malaise
Journal:  Int J Radiat Oncol Biol Phys       Date:  1981-05       Impact factor: 7.038

6.  Dose-rate effects in mammalian cells in culture III. Comparison of cell killing and cell proliferation during continuous irradiation for six different cell lines.

Authors:  J B Mitchell; J S Bedford; S M Bailey
Journal:  Radiat Res       Date:  1979-09       Impact factor: 2.841

7.  In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors.

Authors:  D J Giard; S A Aaronson; G J Todaro; P Arnstein; J H Kersey; H Dosik; W P Parks
Journal:  J Natl Cancer Inst       Date:  1973-11       Impact factor: 13.506

8.  Intracellular myoglobin--a specific marker for skeletal muscle differentiation in soft tissue sarcomas. An immunoperoxidase study.

Authors:  J M Corson; G S Pinkus
Journal:  Am J Pathol       Date:  1981-06       Impact factor: 4.307

9.  An in vitro colony assay for human tumours grown in immune-suppressed mice and treated in vivo with cytotoxic agents.

Authors:  V D Courtenay; J Mills
Journal:  Br J Cancer       Date:  1978-02       Impact factor: 7.640

10.  Cellular repair factors influencing radiocurability of human malignant tumours.

Authors:  R R Weichselbaum; A Schmit; J B Little
Journal:  Br J Cancer       Date:  1982-01       Impact factor: 7.640

View more
  7 in total

1.  Impact of prolonged fraction dose-delivery time modeling intensity-modulated radiation therapy on hepatocellular carcinoma cell killing.

Authors:  Xiao-Kang Zheng; Long-Hua Chen; Xiao Yan; Hong-Mei Wang
Journal:  World J Gastroenterol       Date:  2005-03-14       Impact factor: 5.742

2.  PAX3-FKHR induces morphological change and enhances cellular proliferation and invasion in rhabdomyosarcoma.

Authors:  J Anderson; A Ramsay; S Gould; K Pritchard-Jones
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

3.  In vitro differentiation and proliferation in a newly established human rhabdomyosarcoma cell line.

Authors:  A Ogose; T Motoyama; T Hotta; H Watanabe
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

4.  Induction of myogenic differentiation in human rhabdomyosarcoma cells by ionising radiation, N,N-dimethylformamide and their combination.

Authors:  G Nicoletti; C De Giovanni; L Landuzzi; G Simone; P Rocchi; P Nanni; P L Lollini
Journal:  Br J Cancer       Date:  1992-04       Impact factor: 7.640

5.  In vitro differentiation of rhabdomyosarcomas induced by nickel or by Moloney murine sarcoma virus.

Authors:  P Nanni; G Azzarello; L Tessarollo; C De Giovanni; P L Lollini; G Nicoletti; K Scotlandi; L Landuzzi; M Panozzo; E D'Andrea
Journal:  Br J Cancer       Date:  1991-05       Impact factor: 7.640

6.  Characterization and modulation of drug resistance of human paediatric rhabdomyosarcoma cell lines.

Authors:  H A Cocker; C R Pinkerton; L R Kelland
Journal:  Br J Cancer       Date:  2000-08       Impact factor: 7.640

7.  Human rhabdomyosarcoma cell lines for rhabdomyosarcoma research: utility and pitfalls.

Authors:  Ashley R P Hinson; Rosanne Jones; Lisa E S Crose; Brian C Belyea; Frederic G Barr; Corinne M Linardic
Journal:  Front Oncol       Date:  2013-07-17       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.